Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
European Urology
|
August 6, 2017
Racial Disparity in Delivering Definitive Therapy for Intermediate/High-risk Localized Prostate Cancer: The Impact of Facility Features and Socioeconomic Characteristics
David F Friedlander, Quoc-Dien Trinh, Anna Krasnova, et al.
Urology
|
August 15, 2021
Determining Variable Costs in the Acute Urolithiasis Cycle of Care Through Time-Driven Activity-Based Costing
Tyler R McClintock, David F Friedlander, Aiden Y Feng, et al.
Urologic Oncology
|
August 25, 2018
Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A national cancer database analysis
Philipp Gild, Stephanie A Wankowicz, Akshay Sood, et al.
Urology Practice
|
June 10, 2023
Impact of Accountable Care Organizations on Prostate Cancer Screening and Biopsies in the United States
Quoc-Dien Trinh, Maxine Sun, Anna Krasnova, et al.
The Journal of Urology
|
January 12, 2019
Facility Level Variation in Rates of Definitive Therapy for Low Risk Prostate Cancer in Men with Limited Life Expectancy: An Opportunity for Value Based Care Redesign
David F Friedlander, Nicolas von Landenberg, Björn Löppenberg, et al.
Stem Cells Translational Medicine
|
April 26, 2012
Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells
Tim U Krohne, Peter D Westenskow, Toshihide Kurihara, et al.
Urologic Oncology
|
December 27, 2017
Comparative effectiveness of robot-assisted vs. open radical cystectomy
Nawar Hanna, Jeffrey J Leow, Maxine Sun, et al.
Urologic Oncology
|
May 7, 2019
The current landscape of low-value care in men diagnosed with prostate cancer: what is the role of individual hospitals?
Marieke J Krimphove, Alexander P Cole, David F Friedlander, et al.
Urologic Oncology
|
December 14, 2020
Health care spending in prostate cancer: An assessment of characteristics and health care utilization of high resource-patients
Maxine Sun, Maya Marchese, David F Friedlander, et al.
World Journal of Urology
|
November 1, 2024
Trend of ambulatory benign prostatic obstruction surgeries during COVID-19 pandemic
Zhiyu Qian, Dejan Filipas, Edoardo Beatrici, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
European Urology
|
August 6, 2017
Racial Disparity in Delivering Definitive Therapy for Intermediate/High-risk Localized Prostate Cancer: The Impact of Facility Features and Socioeconomic Characteristics
David F Friedlander, Quoc-Dien Trinh, Anna Krasnova, et al.
Urology
|
August 15, 2021
Determining Variable Costs in the Acute Urolithiasis Cycle of Care Through Time-Driven Activity-Based Costing
Tyler R McClintock, David F Friedlander, Aiden Y Feng, et al.
Urologic Oncology
|
August 25, 2018
Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A national cancer database analysis
Philipp Gild, Stephanie A Wankowicz, Akshay Sood, et al.
Urology Practice
|
June 10, 2023
Impact of Accountable Care Organizations on Prostate Cancer Screening and Biopsies in the United States
Quoc-Dien Trinh, Maxine Sun, Anna Krasnova, et al.
The Journal of Urology
|
January 12, 2019
Facility Level Variation in Rates of Definitive Therapy for Low Risk Prostate Cancer in Men with Limited Life Expectancy: An Opportunity for Value Based Care Redesign
David F Friedlander, Nicolas von Landenberg, Björn Löppenberg, et al.
Stem Cells Translational Medicine
|
April 26, 2012
Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells
Tim U Krohne, Peter D Westenskow, Toshihide Kurihara, et al.
Urologic Oncology
|
December 27, 2017
Comparative effectiveness of robot-assisted vs. open radical cystectomy
Nawar Hanna, Jeffrey J Leow, Maxine Sun, et al.
Urologic Oncology
|
May 7, 2019
The current landscape of low-value care in men diagnosed with prostate cancer: what is the role of individual hospitals?
Marieke J Krimphove, Alexander P Cole, David F Friedlander, et al.
Urologic Oncology
|
December 14, 2020
Health care spending in prostate cancer: An assessment of characteristics and health care utilization of high resource-patients
Maxine Sun, Maya Marchese, David F Friedlander, et al.
World Journal of Urology
|
November 1, 2024
Trend of ambulatory benign prostatic obstruction surgeries during COVID-19 pandemic
Zhiyu Qian, Dejan Filipas, Edoardo Beatrici, et al.
Page
of 8